(RTTNews) - On Thursday, SpyGlass Pharma, Inc. (SGP) announced the acquisition of the outstanding shares of common stock of Advanced Vision Science, Inc., an ophthalmic medical device company, for approximately $13 million in cash.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.